SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-002940
Filing Date
2017-03-29
Accepted
2017-03-29 08:31:39
Documents
60
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 933699
2 ex31.htm EX-31 12086
3 ex32.htm EX-32 6623
  Complete submission text file 0001493152-17-002940.txt   4475750

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20161231.xml EX-101.INS 674604
5 XBRL SCHEMA FILE lixt-20161231.xsd EX-101.SCH 60935
6 XBRL CALCULATION FILE lixt-20161231_cal.xml EX-101.CAL 43604
7 XBRL DEFINITION FILE lixt-20161231_def.xml EX-101.DEF 235104
8 XBRL LABEL FILE lixt-20161231_lab.xml EX-101.LAB 391170
9 XBRL PRESENTATION FILE lixt-20161231_pre.xml EX-101.PRE 302511
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 000-51476 | Film No.: 17720725
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences